annual current liabilities:
$35.59M+$8.32M(+30.50%)Summary
- As of today (July 1, 2025), XENE annual total current liabilities is $35.59 million, with the most recent change of +$8.32 million (+30.50%) on December 31, 2024.
- During the last 3 years, XENE annual current liabilities has risen by +$21.27 million (+148.50%).
- XENE annual current liabilities is now -17.96% below its all-time high of $43.38 million, reached on December 31, 2019.
Performance
XENE Current liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly current liabilities:
$32.03M-$3.56M(-10.00%)Summary
- As of today (July 1, 2025), XENE quarterly total current liabilities is $32.03 million, with the most recent change of -$3.56 million (-10.00%) on March 31, 2025.
- Over the past year, XENE quarterly current liabilities has increased by +$9.81 million (+44.13%).
- XENE quarterly current liabilities is now -33.99% below its all-time high of $48.52 million, reached on March 31, 2020.
Performance
XENE quarterly current liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Current liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
XENE Current liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +30.5% | +44.1% |
3 y3 years | +148.5% | +301.3% |
5 y5 years | -18.0% | -34.0% |
XENE Current liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +148.5% | -10.0% | +133.2% |
5 y | 5-year | -18.0% | +148.5% | -10.0% | +301.3% |
alltime | all time | -18.0% | +1179.3% | -34.0% | +1051.3% |
XENE Current liabilities History
Date | Annual | Quarterly |
---|---|---|
Mar 2025 | - | $32.03M(-10.0%) |
Dec 2024 | $35.59M(+30.5%) | $35.59M(+19.9%) |
Sep 2024 | - | $29.70M(-5.1%) |
Jun 2024 | - | $31.29M(+40.8%) |
Mar 2024 | - | $22.22M(-18.5%) |
Dec 2023 | $27.27M(+20.1%) | $27.27M(+10.2%) |
Sep 2023 | - | $24.74M(-12.1%) |
Jun 2023 | - | $28.16M(+25.2%) |
Mar 2023 | - | $22.49M(-0.9%) |
Dec 2022 | $22.70M(+58.5%) | $22.70M(+46.1%) |
Sep 2022 | - | $15.54M(+13.1%) |
Jun 2022 | - | $13.74M(+72.1%) |
Mar 2022 | - | $7.98M(-44.3%) |
Dec 2021 | $14.32M(-3.1%) | $14.32M(+11.4%) |
Sep 2021 | - | $12.86M(-14.2%) |
Jun 2021 | - | $14.98M(+30.4%) |
Mar 2021 | - | $11.49M(-22.3%) |
Dec 2020 | $14.78M(-65.9%) | $14.78M(-12.6%) |
Sep 2020 | - | $16.92M(-19.7%) |
Jun 2020 | - | $21.05M(-56.6%) |
Mar 2020 | - | $48.52M(+11.9%) |
Dec 2019 | $43.38M | $43.38M(+270.9%) |
Sep 2019 | - | $11.70M(+25.4%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2019 | - | $9.33M(+46.3%) |
Mar 2019 | - | $6.38M(+54.8%) |
Dec 2018 | $4.12M(+0.9%) | $4.12M(-6.7%) |
Sep 2018 | - | $4.41M(+42.6%) |
Jun 2018 | - | $3.09M(-18.3%) |
Mar 2018 | - | $3.79M(-7.2%) |
Dec 2017 | $4.08M(+13.9%) | $4.08M(+33.5%) |
Sep 2017 | - | $3.06M(-19.0%) |
Jun 2017 | - | $3.77M(+5.1%) |
Mar 2017 | - | $3.59M(+0.1%) |
Dec 2016 | $3.59M(+28.9%) | $3.59M(-9.8%) |
Sep 2016 | - | $3.98M(+35.7%) |
Jun 2016 | - | $2.93M(+2.0%) |
Mar 2016 | - | $2.87M(+3.2%) |
Dec 2015 | $2.78M(-80.5%) | $2.78M(-47.9%) |
Sep 2015 | - | $5.34M(-55.6%) |
Jun 2015 | - | $12.02M(+17.2%) |
Mar 2015 | - | $10.25M(-28.2%) |
Dec 2014 | $14.29M(-21.5%) | $14.29M(-12.6%) |
Sep 2014 | - | $16.34M(-5.2%) |
Jun 2014 | - | $17.23M(-5.3%) |
Dec 2013 | $18.20M(-5.2%) | $18.20M |
Dec 2012 | $19.20M | - |
FAQ
- What is Xenon Pharmaceuticals annual total current liabilities?
- What is the all time high annual current liabilities for Xenon Pharmaceuticals?
- What is Xenon Pharmaceuticals annual current liabilities year-on-year change?
- What is Xenon Pharmaceuticals quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Xenon Pharmaceuticals?
- What is Xenon Pharmaceuticals quarterly current liabilities year-on-year change?
What is Xenon Pharmaceuticals annual total current liabilities?
The current annual current liabilities of XENE is $35.59M
What is the all time high annual current liabilities for Xenon Pharmaceuticals?
Xenon Pharmaceuticals all-time high annual total current liabilities is $43.38M
What is Xenon Pharmaceuticals annual current liabilities year-on-year change?
Over the past year, XENE annual total current liabilities has changed by +$8.32M (+30.50%)
What is Xenon Pharmaceuticals quarterly total current liabilities?
The current quarterly current liabilities of XENE is $32.03M
What is the all time high quarterly current liabilities for Xenon Pharmaceuticals?
Xenon Pharmaceuticals all-time high quarterly total current liabilities is $48.52M
What is Xenon Pharmaceuticals quarterly current liabilities year-on-year change?
Over the past year, XENE quarterly total current liabilities has changed by +$9.81M (+44.13%)